Biotech Products Services & Research, Inc is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
FORT LAUDERDALE, FL / ACCESSWIRE / November 27, 2023 / Organicell Regenerative Medicine Inc, (OTCQB:OCEL) ("Organicell" or the "Company"), today announced that it is implementing a 1-for-200 Reverse ...
FORT LAUDERDALE, FL / ACCESSWIRE / June 21, 2023 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological ...
Organicell Regenerative Medicine, Inc . is pleased to announce the appointment of Harry L. Leider, MD, MBA as its new Chief Executive Officer (CEO). FORT LAUDERDALE, FL / ACCESSWIRE / June 21, 2023 / ...
DAVIE, FL / ACCESSWIRE / November 21, 2022 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL) ("Organicell" or the "Company") has been requested by OTC Markets Group, Inc. ("OTC Markets") to issue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results